 | Up a level |
Hoeglinger, G., Respondek, G., Stamelou, M., Kurz, C., Josephs, K., Lang, A., Mollenhauer, B., Mueller, U., Nilsson, C., Whitwell, J., Arzberger, T., Gelpi, E., Giese, A., Irwin, D., Meissner, W., Pantelyat, A., van Swieten, J., Troakes, C., Antonini, A., Bhatia, K., Bordelon, Y., Corvol, J. C., Colosimo, C., Dodel, R., Grossman, M., Kassubek, J., Krismer, F., Levin, J., Morris, H., Nestor, P., Oertel, W., Rabinovici, G., Rowe, J., van Eimeren, T., Wenning, G., Yu, J. -T., Golbe, L. I., Litvan, I. and Boxer, A. (2016). Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP). J. Neurochem., 138. S. 364 - 365. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159
Nobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., Walker, Z. and Boccardi, M. (2018). European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur. J. Neurol., 25 (10). S. 1201 - 1218. HOBOKEN: WILEY. ISSN 1468-1331